Clinical Trial Update: SLC13A5 Deficiency Natural History Study - United States Only

View source ↗

Summary

This is a US-only natural history study of SLC13A5 deficiency (citrate transporter deficiency) that is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Developmental and Epileptic Encephalopathy 25
• Epilepsy
• Infantile Epileptic Encephalopathy 25
• Kohlschütter-tönz Syndrome
• Slc13a5 Deficiency

Snippet

Sponsor: TESS Research Foundation | Conditions: Citrate Transporter Deficiency, Epilepsy | Status: ENROLLING_BY_INVITATION